How AskBio Re-Aligned Its Leadership for Breakthrough Growth

When AskBio approached The Zone Global, the company was at an exciting inflection point. Rapid growth. Breakthrough science. Expanding global ambition.

As a leader in gene therapy innovation and a subsidiary of Bayer AG, AskBio was accelerating clinical programs, scaling teams, and pushing scientific boundaries. But with that momentum came pressure.

The leadership team was navigating complexity on multiple fronts — regulatory milestones, scientific advancement, operational scale, and cross-functional collaboration. The mission was clear. The ambition was bold. Yet the pace of growth meant alignment was being stretched, decision fatigue was creeping in, and new milestones were beginning to feel harder to reach.

The Leadership Tension

High-growth environments create a paradox.

Innovation demands space to experiment and learn.
Scale demands structure.
Breakthrough science demands precision.

Without deliberate leadership discipline, even the strongest executive teams can drift into reactive rhythms, constantly responding rather than strategically steering.

AskBio didn’t need more intelligence. They didn’t need more ambition.
They needed sharper alignment, stronger executive cohesion, and a performance framework that could match their scientific velocity.

Enter The Zone Global

The Zone Global lead by Sebastien Meyer, partnered directly with senior leaders to strengthen focus, strategic clarity, and executive presence with Leadership Development, Executive Coaching, and High Performance Team Programs.

This wasn’t generic leadership training. It was practical, high-performance coaching embedded into the realities of a fast-moving biotech organisation. Together, the work focused on:

• Elevating decision-making clarity
• Aligning leadership priorities across functions
• Embedding consistent performance rhythms
• Strengthening communication and executive influence

In the testimonial shared by AskBio’s leadership, one theme stands out: clarity. Leaders described how the engagement helped crystallise thinking, reduce noise, and create shared language around performance and accountability.

What Changed

The impact was tangible.

Executive alignment sharpened.
Strategic priorities became more explicit and consistently reinforced.

Decision discipline improved.
Leaders moved from reactive problem-solving to proactive direction-setting.

Cross-functional collaboration strengthened.
Scientific, clinical, and operational teams operated with greater cohesion.

Most importantly, the leadership team felt re-anchored — confident in their ability to meet ambitious milestones without losing focus or burning out.

Sustaining Innovation at Scale

In an industry where complexity only increases — from clinical trials to regulatory engagement — leadership capability becomes a competitive advantage.

By investing in executive alignment and performance habits, AskBio didn’t just address short-term pressure. They strengthened the foundation required to sustain innovation long term.

Breakthrough science requires breakthrough leadership.

And when focus, clarity, and cohesion come together — performance accelerates.

‍

The Results Speak For Themself

In our work with AskBio, we saw a leadership team under immense pressure — balancing scientific innovation, regulatory complexity, and ambitious growth targets. Through focused executive coaching and alignment work, we helped the team shift from reactive execution to disciplined, strategic focus. By creating clarity around priorities, strengthening cross-functional decision-making, and embedding high-performance leadership rhythms, AskBio regained momentum where it mattered most. As a direct result, the organisation caught up on critical development timelines and successfully advanced multiple programs from pre-clinical stages into Phase II — a significant milestone in the demanding field of gene therapy.

‍